What is the global market size of Veterinary Immunodiagnostics Market?

Veterinary Immunodiagnostics Market size was valued at USD 2183.35 million in 2019 and is poised to grow from USD 2375.1 million in 2023 to USD 4663.51 million by 2031, growing at a CAGR of 8.8% in the forecast period (2024-2031).

Who are the key vendors in the Global Veterinary Immunodiagnostics Market?

Pet adoption is on the rise right now because studies show that they help people's mental health. People are willing to spend a sizable amount of money to improve the health of their pets because they are worried about it. The participants have joined forces with a number of other businesses or 'IDEXX Laboratories, Inc. (US)', 'Zoetis Inc. (US)', 'Thermo Fisher Scientific Inc. (US)', 'Heska Corporation', 'Abaxis, Inc.', 'Virbac SA', 'Neogen Corporation', 'BioMérieux SA', 'Idexx Reference Laboratories', 'Randox Laboratories Ltd.', 'VCA, Inc.', 'Covance Inc.', 'IDVet', 'INGENASA', 'Creative Diagnostics', 'Eurofins Scientific SE', 'ProtaTek International Inc.', 'Agrolabo S.p.A.', 'Fujirebio Inc.', 'Bio-Rad Laboratories, Inc.'

Veterinary Immunodiagnostics Market Size

Veterinary Immunodiagnostics Market Insights

Global Veterinary Immunodiagnostics Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.92 billion in 2024 to USD 5.44 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The rising incidence of animal disease, the availability of disease-specific immunodiagnostic tests, and improvements in immunodiagnostic technology all contribute to the market's expansion. Additionally, the rise in the number of pets and the demand for foods derived from animals both contribute to the expansion of this market. Opportunities for the expansion of this market are expected to be created by emerging economies. The development of the veterinary immunodiagnostics market, however, is anticipated to face significant obstacles due to the underdeveloped veterinary diagnostics infrastructure in developing nations.

There are more people and animals being tested because COVID-19 is becoming more common worldwide. Players and reference labs have also been prompted by this to create new and improved animal tests. The AVMA, CDC, USDA, American Association of Veterinary Laboratory Diagnosticians (AAVLD), National Association of State Public Health Veterinarians (NASPHV), and the National Assembly of State Animal Health Officials do not advocate routine COVID-19 testing of animals. Animal testing may be decided upon by public and animal health officials due to the constantly changing situation. The attending veterinarian, as well as representatives from the local, state, and/or federal public health and animal health departments, should jointly decide whether to conduct the test.

US Veterinary Immunodiagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.

FAQs

Pet adoption is on the rise right now because studies show that they help people's mental health. People are willing to spend a sizable amount of money to improve the health of their pets because they are worried about it. The participants have joined forces with a number of other businesses or 'IDEXX Laboratories, Inc. (USA) ', 'Zoetis Inc. (USA) ', 'Thermo Fisher Scientific Inc. (USA) ', 'bioMerieux SA (France) ', 'Heska Corporation (USA) ', 'NEOGEN Corporation (USA) ', 'Bio-Rad Laboratories, Inc. (USA) ', 'Virbac (France) ', 'FUJIFILM Holdings Corporation (Japan) ', 'Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) ', 'INDICAL BIOSCIENCE GmbH (Germany) ', 'BioNote, Inc. (South Korea) ', 'Biogal Galed Labs (Israel) ', 'Agrolabo S.p.A. (Italy) ', 'IDvet (France) ', 'Randox Laboratories Ltd. (UK) ', 'BioChek (Netherlands) ', 'Biopanda Reagents (UK) ', 'URIT Medical Electronic Co., Ltd. (China) ', 'Bionote, Inc. (South Korea)'

At least 30 serious illnesses that affect people can be spread by animals. The majority of human infections are spread by livestock and companion animals (like dogs and cats) (such as pigs, chickens, cattle, goats, and camels). Major zoonotic illnesses that spread from animals to people include rabies, leptospirosis, cysticercosis, zoonotic tuberculosis, and gastrointestinal disease.

A number of zoonotic and vector-borne diseases are likely to become more common in the near future as a result of shifting social norms, habitat modification, the introduction of exotic vectors, and climate change. The need for quick and accurate diagnostic tools to stop these diseases will therefore drive the development of veterinary infectious disease diagnostics. According to the forecast, the development of companion animal medicine in developed nations will lead to further growth in the global market for veterinary infectious disease diagnostics. Furthermore, there is already a greater market demand for technologically advanced diagnostic techniques like RT PCR than there is for traditional diagnostic techniques.

Throughout the forecast period, North America is anticipated to continue to hold a commanding position in the veterinary immunodiagnostics market. The expansion of products on the market, the sizable stakes held by the major players in the area, and the rising accessibility and affordability of early detection all contribute to this dominance. The market in Asia Pacific is anticipated to expand at the fastest rate during the forecast period due to rising pet adoption rates, zoonotic disease occurrences, and a rise in the need for diagnostics for infectious diseases in livestock.